IFN alpha 2a Protein
Conditions of optimal IFN alpha 2a Protein performance should be determined experimentally by the investigator.
Conditions of optimal IFN alpha 2a Protein performance should be determined experimentally by the investigator.
Cintirorgon (CAS No.: 2055536-64-4), is a first-in-class, selective and orally bioavailable RORγ agonist. Cintirorgon (LYC-55716) modulates gene expression of RORγ expressing T lymphocyte immune cells, resulting in enhanced effector function, as well as decreased immunosuppression,...
M-3258 (CAS No.: 2285330-15-4), orally bioavailable, potent, reversible and highly selective immunoproteasome subunit LMP7 (β5i) inhibitor. M3258 exerts high biochemical (IC50=3.6 nM) and cellular (IC50=3.4 nM) potency against the LMP7 subunit. Synonyms: M3258, M 3258, M-3258,...
M-2698 (CAS No.: 1379545-95-5), is an orally active, ATP competitive, selective p70S6K and Akt dual-inhibitor with IC50s of 1 nM for p70S6K, Akt1 and Akt3. >98% Purity. Synonyms: MSC2363318A, M2698, p70S6 inhibitor, Akt inhibitor For Research Use...